AVITA Medical, Inc. Payments to Acquire Marketable Securities
AVITA Medical, Inc. (AVHHL) reported Payments to Acquire Marketable Securities of $3.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-06
- AVITA Medical, Inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $0.00.
- AVITA Medical, Inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $3.94M.
- AVITA Medical, Inc. payments to acquire marketable securities for the quarter ending 2025-12-31 was $1.96M, a 66.70% decline year-over-year.
- AVITA Medical, Inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $7.89M, a 38.34% decline year-over-year.
- AVITA Medical, Inc. payments to acquire marketable securities for fiscal 2025 was $13.31M, a 45.69% decline from fiscal 2024.
- AVITA Medical, Inc. payments to acquire marketable securities for fiscal 2024 was $24.50M, a 68.89% decline from fiscal 2023.
- AVITA Medical, Inc. payments to acquire marketable securities for fiscal 2023 was $78.76M, a 5.91% increase from fiscal 2022.
- AVITA Medical, Inc. payments to acquire marketable securities for fiscal 2022 was $74.36M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.94M 10-Q · filed 2026-08-06 | $5.90M derived: sum of 3 quarters · filed 2026-08-06 | $13.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.94M 10-Q · filed 2026-05-14 | $5.90M derived: sum of 2 quarters · filed 2026-05-14 | $13.79M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $9.85M derived: sum of 2 quarters · filed 2026-02-12 | $13.31M 10-K · filed 2026-02-12 | |
| 2025-09-30 | $7.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $11.35M 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $3.46M 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $18.68M derived: sum of 2 quarters · filed 2026-02-12 | $21.60M derived: sum of 3 quarters · filed 2026-02-12 | $24.50M 10-K · filed 2026-02-12 |
| 2024-09-30 | $12.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $15.71M derived: sum of 2 quarters · filed 2025-11-06 | $18.61M 10-Q · filed 2025-11-06 | $89.73M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $5.82M 10-Q · filed 2025-08-08 | $76.94M derived: sum of 3 quarters · filed 2025-08-08 | $76.94M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $2.90M 10-Q · filed 2025-05-08 | $74.03M derived: sum of 2 quarters · filed 2025-05-08 | $74.03M derived: sum of 3 quarters · filed 2025-05-08 | $76.48M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $71.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $71.12M derived: sum of 2 quarters · filed 2025-02-13 | $73.57M derived: sum of 3 quarters · filed 2025-02-13 | $78.76M 10-K · filed 2025-02-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.45M derived: sum of 2 quarters · filed 2024-11-07 | $7.63M 10-Q · filed 2024-11-07 | $22.59M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $7.63M 10-Q · filed 2024-08-08 | $22.59M derived: sum of 3 quarters · filed 2024-08-08 | $49.02M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $5.18M 10-Q · filed 2024-05-13 | $20.14M derived: sum of 2 quarters · filed 2024-05-13 | $46.57M derived: sum of 3 quarters · filed 2024-05-13 | $54.02M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $14.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $41.39M derived: sum of 2 quarters · filed 2024-02-22 | $48.84M derived: sum of 3 quarters · filed 2024-02-22 | $74.36M 10-K · filed 2024-02-22 |
| 2022-09-30 | $26.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $33.88M derived: sum of 2 quarters · filed 2023-11-09 | $59.41M 10-Q · filed 2023-11-09 | $59.41M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $7.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $32.98M 10-Q · filed 2023-08-10 | $32.98M derived: sum of 3 quarters · filed 2023-08-10 | $82.53M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $25.52M 10-Q · filed 2023-05-11 | $25.52M derived: sum of 2 quarters · filed 2023-05-11 | $75.08M derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2023-02-23 | $49.55M 10-K · filed 2023-02-23 | ||
| 2021-09-30 | $49.55M 10-Q · filed 2021-11-08 | $49.55M 10-Q · filed 2022-11-10 |